// App-Quantinova.ai

P615 : Efficacy of vedolizumab in patients with Crohn's disease may differ depending on the disease location: The UCLH experience

Researchers

Presenter

  • T Kumagai

Principal Investigators

  • M Vinayaga-Pavan

  • I Parisi

  • J Barragry

  • R Sundramoorthi

  • L Whitley

  • H Parker

  • R Kettle

  • N McCabrey

  • E Seward

  • S McCartney

  • S Bloom

  • R Vega

  • S Mehta

  • F Rahman

Medical Centers

  • University College London Hospital, Gastroenterology, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved